Sevgia

Sevgia Uses, Dosage, Side Effects, Food Interaction and all others data.

Sevgia Hydrochloride is a new treatment for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis. Elevated serum phosphorus levels or uncontrolled hyperphosphatemia leads to development of secondary hyperparathyroidism, renal bone disease, calcification of vascular and nonvascular tissues, and cardiovascular disease. It is a calcium-free and aluminium-free nonabsorbed polymer phosphate binder, it does not cause calcium and aluminium toxicity. When taken with meals it inhibits intestinal absorption of ingested phosphate.

Patients with end-stage renal disease (ESRD) retain phosphorus and can develop hyperphosphatemia. High serum phosphorus can precipitate serum calcium resulting in ectopic calcification. When the product of serum calcium and phosphorus concentrations (Ca x P) exceeds 55 mg2/dL2, there is an increased risk that ectopic calcification will occur. Hyperphosphatemia plays a role in the development of secondary hyperparathyroidism in renal insufficiency. An increase in parathyroid hormone (PTH) levels is characteristic of patients with chronic renal failure. Increased levels of PTH can lead to osteitis fibrosa, a bone disease. A decrease in serum phosphorus may decrease serum PTH levels. Treatment of hyperphosphatemia includes reduction in dietary intake of phosphate, inhibition of intestinal phosphate absorption with phosphate binders, and removal of phosphate with dialysis. Sevgia taken with meals has been shown to decrease serum phosphorus concentrations in patients with ESRD who are on hemodialysis. In vitro studies have shown that the capsule and tablet formulations bind phosphate to a similar extent. Sevgia treatment also results in a lowering of low-density lipoprotein (LDL) and total serum cholesterol levels.

Trade Name Sevgia
Availability Prescription only
Generic Sevelamer
Sevelamer Other Names Sevelamer, Sévélamer, Sevelamero, Sevelamerum
Related Drugs sucralfate, Carafate, Renvela, Auryxia, Velphoro, Renagel
Type Tablet
Formula C6H12ClNO
Weight Average: 149.619
Monoisotopic: 149.060741718
Groups Approved
Therapeutic Class Drugs for reduction of serum phosphorus in patients with ESRD
Manufacturer Hygeia Pharmaceuticals
Available Country India
Last Updated: September 19, 2023 at 7:00 am
Sevgia
Sevgia

Uses

Sevgia Hydrochloride is used for the reduction of serum phosphorus in patients with end-stage renal disease (ESRD).

Sevgia is also used to associated treatment for these conditions: Hyperphosphataemia

How Sevgia works

Sevgia prevents hyperphosphatemia by binding to dietary phosphate in the gut, preventing its absorption and thus decreasing serum parathyroid hormone levels.

Dosage

Sevgia dosage

Patients not taking a Phosphate Binder: The recommended starting dose of Sevgia is 800 to 1600 mg, which can be administered as two to four 400 mg Sevgia tablets, with meals based on serum phosphorus level. Renophos 400 Recommendation for the patients with hyperphosphatemia is given below-

Starting dose of Renophos for dialysis patients not taking any phosphate binder:

  • Serum Phosphorus >5.5 and <7.5 mg/dL: 800 mg (2 tablets) three times daily with meals
  • Serum Phosphorus ≥7.5 and <9.0 mg/dL: 1200 mg (3 tablets) three times daily with meals
  • Serum Phosphorus ≥9.0 mg/dL: 1600 mg (4 tablets) three times daily with meals

Starting dose for dialysis patients switching from calcium acetate to Sevgia:

  • Calcium Acetate 667 mg (1 tablet): Sevgia 800 mg (2 tablets)
  • Calcium Acetate 1334 mg (2 tablets): Sevgia 1200 mg (3 tablets)
  • Calcium Acetate 2001 mg (3 tablets): Sevgia 2000 mg (5 tablets)

Dose titration guideline:

  • Serum Phosphorus >5.5 mg/dL: Increase 400 mg (1 tablet) per meal at 2 week intervals
  • Serum Phosphorus 3.5-5.5 mg/dL: Maintain current dose
  • Serum Phosphorus <3.5 mg/dL: Decrease 400 mg (1 tablet) per meal

Dose titration for all patients taking Sevgia: Dosage should be adjusted based on the serum phosphorus concentration with a goal of lowering serum phosphorus to 5.5 mg/dl or less. The dose may be increased or decreased by one tablet per meal at two week intervals as necessary.

Side Effects

Sevgia may cause dyspepsia, peritonitis, diarrhea, nausea, constipation, pruritus, abdominal distension, vomiting, fatigue, anorexia, arthralgia and less commonly ileus, bowel obstruction and bowel perforation.

Toxicity

Sevgia has been given to normal healthy volunteers in doses of up to 14 grams per day for eight days with no adverse effects. Sevgia has been given in average doses up to 13 grams per day to hemodialysis patients. There are no reported overdosages of sevelamer in patients. Since sevelamer is not absorbed, the risk of systemic toxicity is low.

Precaution

The safety and efficacy of Sevgia in patients with dysphagia, swallowing disorders, severe GI motility disorders including severe constipation, or major GI tract surgery have not been established. Caution should be exercised when Sevgia is used in patients with these GI disorders.

Interaction

Sevgia has been studied in human drug-drug interaction studies with ciprofloxacin, digoxin, warfarin, enalapril, metoprolol and iron.

Food Interaction

  • Take with food.

[Moderate] ADJUST DOSING INTERVAL: Sevgia may decrease the oral bioavailability of concomitantly administered drugs. While clinical data are lacking for most drugs, the intestinal absorption of some may be impaired due to sevelamer's binding capabilities.

MANAGEMENT: As a precaution, drugs that can be adversely affected by alterations in blood levels should be administered 1 hour before or 3 hours after sevelamer.

Sevgia multivitamins interaction

[Moderate] ADJUST DOSING INTERVAL: Bile acid sequestrants and the phosphate binder, sevelamer, can decrease the absorption of fat-soluble vitamins A, D, E, and K.

In non-clinical safety studies, rats administered colesevelam at doses greater than 30-fold the projected human clinical dose developed hemorrhage in association with vitamin K deficiency.

In a crossover study involving healthy subjects, coadministration of sevelamer with calcitriol resulted in a significant reduction in bioavailability for calcitriol (calcitriol with sevelamer vs calcitriol alone: AUC 137 pg*h
Oral vitamin supplements should be administered at least 4 hours before colesevelam and either 1 hour before or 4 to 6 hours after other bile acid sequestrants and sevelamer.

Elimination Route

Not absorbed following oral administration, however no absorption studies have been performed in patients with renal disease. Sevgia may bind to dietary phosphates and prevent its gastrointestinal absorption when sevelamer is administered in combination with food.

Pregnancy & Breastfeeding use

Pregnancy Category C. No adequate and controlled studies have been conducted using Sevgia in nursing mothers. Sevgia should be used during breastfeeding only if the potential benefit justifies the potential risks.

Contraindication

Sevgia is contraindicated in patients with hypophosphatemia or bowel obstruction and in patients with known hypersensitivity to Sevgia hydrochloride or any of its constituents.

Acute Overdose

Over dosages of Sevgia in patients was never reported. Since Sevgia is not absorbed, the risk of systemic toxicity is low.

Innovators Monograph

You find simplified version here Sevgia

FAQ

What is Sevgia used for?

Sevgia is used to control high blood levels of phosphorus in people with chronic kidney disease who are on dialysis .

How does a Sevgia work?

Sevgia works by lowers your blood phosphorus levels to help protect your kidneys and bones.

What are the common side effects of Sevgia?

Sevgia may cause common side effects are include:

  • diarrhea.
  • vomiting.
  • nausea.
  • stomach pain.
  • gas.
  • heartburn.
  • new or worsening constipation.

Is Sevgia safe during pregnancy?

Sevgia products should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. The effect of Sevgia hydrochloride on the absorption of vitamins and other nutrients has not been studied in pregnant women.

Is Sevgia safe during breastfeeding?

Sevgia is not absorbed into the bloodstream, it is not expected to be harmful to a nursing baby.The non-absorbed nature of this drug makes its excretion in human breast milk unlikely. No adequate and controlled studies have been conducted in nursing mothers.

When should Sevgia be given?

It is usually taken three times a day with meals. Follow the directions on your prescription label carefully.

Can Sevgia tablets be crushed?

Sevgia tablets may be crushed and administered via enteral feeding tubes, provided clear instruction on tablet preparation is included.

Can I overdose on Sevgia?

If Sevgia is administered by a healthcare provider in a medical setting, it is unlikely that an overdose will occur. However, if overdose is suspected, seek emergency medical attention.

How to use Sevgia?

Take this medication by mouth as directed by your doctor, usually 3 times daily with meals. Swallow the tablet whole. Do not crush, chew, or split the tablet. The dosage is based on your medical condition, any other medications you take to lower your phosphate levels, and your response to treatment. In children, the dosage is also based on body size.

Can I chew Sevgia?

Swallow the tablet whole.Do not crush, chew, or split the tablet.

Does Sevgia effect my kidney?

 Sevgia lowers phosphorus levels in people with kidney disease on dialysis. Take  with meals.

What happens if I stop taking Sevgia?

If you stop taking Sevgia, your phosphate levels may rise again. It is important to keep taking your medicines even if you feel well. Do not stop taking Sevgia.

What is the reason for taking Sevgia with food?

Sevgia should be taken three times a day with meals to help control phosphorus levels in your body. Sevgia binds to (or holds on to) phosphorus in the foods you eat so your body doesn't absorb as much.

Does Sevgia increase calcium?

Sevgia does not contain calcium or metal and is not absorbed, so it does not build up in your body.

How many times a day can I take Sevgia?

Sevgia takes 3 times per day with meals. As directed by your doctor.

What happens if I miss a dose of Sevgia?

Take the missed dose as soon as you remember. Be sure to take the missed dose with food. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

*** Taking medicines without doctor's advice can cause long-term problems.
Share